About Biolog-id
Biolog-id is a Healthcare company based in Bernay (France) founded in 2005 by Jean-Claude Mongrenier. Developer of traceability solutions for health products. Biolog-id has raised $33.22 million across 3 funding rounds from investors including Xerys and Altamira Capital Partners. The company has 6 employees. Its chief executive, as recorded, is Bruno Chappert. Its Indian entity Biolog - Id India Private Limited reported revenue of ₹3.47 Cr. Biolog-id offers products and services including Biolog Transfusion Solution, Biolog Plasma Solution, and Biolog Oncology Solution. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions.
Company details
Biolog-id was founded in 2005 in Bernay, France, where traceability solutions for health products are developed. Operations focus on the biotech sector, targeting labile blood products such as packed red blood cells, platelets, and therapeutic plasma, as well as plasma for fractionation and chemotherapy injectables. Services ensure product monitoring and compliance across the supply chain in the healthcare industry.
- Headquarters Bernay, France
- Employees 6
- Founders Jean-Claude Mongrenier
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biolog-id.com
- Social LinkedIn YouTube
- Legal Name Biolog - Id India Private Limited
- Date of Incorporation 13 May, 2021
- Jurisdiction Delhi, India
- Indian entity revenue₹3.47 Cr
FY 2025 · +35% YoY
- Indian entity net loss-₹1.29 Cr
FY 2025 · -37% margin
- Indian entity EBITDA-₹90 Lakh
FY 2025 · -26% margin
- Total Equity Funding$33.22M (USD)
in 3 rounds
- Latest Funding Round$33.22M (USD), Series B
Nov 2019
- InvestorsXerys
& 1 more
- Employee Count6
Associated legal entities of Biolog-id
Biolog-id operates through Biolog - Id India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biolog - Id India Private Limited CIN U33119DL2021FTC381061 | Active | 13 May 2021 | Delhi, Delhi | ₹3.5 Cr | 6 | 2 | View details |
Products & Services of Biolog-id
Biolog-id offers a comprehensive portfolio of products and services, including Biolog Transfusion Solution, Biolog Plasma Solution, and Biolog Oncology Solution.
Manages blood products from donation to transfusion for better chain control.
Ensures full traceability of plasma for medicinal product compounding.
Optimizes workflow for secure injectable therapies administration.
Apps and channels of Biolog-id
its YouTube channel biolog-id has 214 subscribers and 21 videos.
Videos from Biolog-id
The most watched videos on Biolog-id's YouTube channel, biolog-id (214 subscribers). Click a video to play it here.
More on biolog-id.
Funding Insights of Biolog-id
Biolog-id has successfully raised a total of $33.22M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $33.22 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33.22M
- Total Rounds 3
- Last Round Series B — $33.22M
- Investors Count 2
All 3 funding rounds of Biolog-id with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Biolog-id
Biolog-id has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Xerys and Altamira Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Xerys is engaged in private equity investment management. | 2014 | xerys.com | Paris, France | |
European private equity investments are managed by the firm. | altamiracap.com | Barcelona, Spain |
Investor details for Biolog-id
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biolog - Id India Private Limited (Biolog-id)
Biolog - Id India Private Limited is the primary company behind Biolog-id. The board of Biolog - Id India Private Limited currently have 2 directors; the longest-serving is Deepak Singh, appointed in 2021. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Deepak Singh DIN 09172601 | Managing Director | 13 May 2021 | 5 yrs 5 mo | Biolog - Id India Private Limited |
| Ludovic Vincent Daprea DIN 11448519 | Additional Director | 30 Dec 2025 | 10 mo | Biolog - Id India Private Limited |
People of Biolog-id
21 people are tracked at Biolog-id (9 in leadership, 12 in team); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
Jean-Claude Mongrenier | Founder & President | Leadership |
| CEO | Leadership | |
Alexandre Guémard | Sales Director Healthcare France | Leadership |
Valérie Declèves | VP Sales EMEA | Leadership |
Armand Leger | Director Of Operations | Leadership |
Philippe Jacquet | Executive Director - Sales (EMEA & LATAM) | Leadership |
Sébastien Damiens | Development and integration Director | Leadership |
Chris Andersen | Managing Director | Leadership |
Arnaud Saint-Michel | Group CFO | Leadership |
Aissa Yagoub | Sales & Application Engineer | Team |
Philippe Cordier | RESPONSABLE COMMERCIAL | Team |
Greg Magda | National Sales Executive | Team |
Javier Gonzalez | Natonal Sales Manager | Team |
Cyrille Grossin | Software Test Manager | Team |
Christophe PERNOM | Application Engineer | Team |
Abhinav Dwivedi | Application Engineer | Team |
Annalisa Starace | Regional Sales Manager | Team |
Giuliano Sciacca | Sales Representative | Team |
Kévin CALEIRA | Directeur commercial | Team |
Christopher Rau, MBA | System Technology Manager / Sr. Systems Engineer | Team |
1 more people are available in the full profile.
Complete people profiles for Biolog-id
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Biolog-id
Figures of Biolog - Id India Private Limited, the primary company behind Biolog-id, for FY 2025. Revenue was ₹3.47 Cr (+35% year on year). Net loss was -₹1.29 Cr (-37% margin). EBITDA was -₹90 Lakh (-26% margin).
- ₹3.47 CrRevenue · FY 2025 · +35% YoY
- -₹1.29 CrNet loss · -37% margin
- -₹90 LakhEBITDA · -26% margin
- ₹6.00 CrPaid-up capital
- 6Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Biolog - Id India Private Limited are on its company page.
Detailed financial statements for Biolog-id
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Biolog-id
3 dated milestones of Biolog-id across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Biolog-id is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $33.2M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biolog-Id
Complete news archive for Biolog-id
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolog-id
Biolog-id was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Biolog-id is headquartered in Bernay, France. It is registered at Bernay, Eure, France.
Bruno Chappert is the CEO of Biolog-id, as recorded in our data.
Biolog-id is a funded company, having raised a total of $33.22M across 3 funding rounds to date.
Biolog-id has 6 employees.
The primary company behind Biolog-id, Biolog - Id India Private Limited, reported revenue of ₹3.47 Cr for FY 2025, up 35% year on year.
Biolog-id was founded in 2005 in Bernay, France, where traceability solutions for health products are developed. Operations focus on the biotech sector, targeting labile blood products such as packed red blood cells, platelets, and therapeutic plasma, as well as plasma for fractionation and chemotherapy injectables. Services ensure product monitoring and compliance across the supply chain in the healthcare industry.
Biolog-id offers Biolog Transfusion Solution, Biolog Plasma Solution, and Biolog Oncology Solution.
Biolog-id has 2 investors. Key investors include Xerys, and Altamira Capital Partners.
Biolog-id operates through Biolog - Id India Private Limited.
The legal entities of Biolog-id currently have 2 directors, including Deepak Singh, Ludovic Vincent Daprea.